FDA 483 - Surgical Design Corp - January 30, 2020

Surgical Design Corp, a distributor located in Armonk, NY, underwent an FDA inspection that identified two significant observations. The firm failed to maintain adequate complaint files and lacked a written complaint handling procedure. Additionally, the company did not clearly define control over its suppliers and contractors, specifically lacking written quality agreements with its product distributor.